GB9929865D0
(en)
*
|
1999-12-18 |
2000-02-09 |
Smith David S Packaging |
Carton opening arrangement
|
US6578736B2
(en)
|
2001-01-09 |
2003-06-17 |
Riverwood International Corporation |
Carton with an improved dispensing feature
|
US20040089671A1
(en)
|
2002-11-07 |
2004-05-13 |
The C.W. Zumbiel Company |
Carton with dispenser
|
US6918487B2
(en)
|
2003-02-12 |
2005-07-19 |
Graphic Packaging International, Inc. |
Dispensing system for double stack carton
|
US7614497B2
(en)
|
2003-10-15 |
2009-11-10 |
Graphic Packaging International, Inc. |
Display/vending carton
|
US7004897B2
(en)
*
|
2003-10-15 |
2006-02-28 |
Graphic Packaging International, Inc. |
Display/vending carton
|
AU2005249212B2
(en)
|
2004-05-28 |
2010-05-20 |
Glaxosmithkline Biologicals S.A. |
Vaccine compositions comprising virosomes and a saponin adjuvant
|
GB0503337D0
(en)
|
2005-02-17 |
2005-03-23 |
Glaxosmithkline Biolog Sa |
Compositions
|
AU2006223032B2
(en)
|
2005-03-14 |
2010-04-08 |
Graphic Packaging International, Inc. |
Cartons with dispenser sections
|
JP5869744B2
(en)
|
2005-03-23 |
2016-02-24 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
Use of influenza virus and oil-in-water emulsion adjuvants to induce CD4 T cell and / or improved memory B cell responses
|
ES2393740T3
(en)
|
2005-05-03 |
2012-12-27 |
Graphic Packaging International, Inc. |
Cardboard container with distributor
|
CA2623193C
(en)
|
2005-09-23 |
2010-11-30 |
Graphic Packaging International, Inc. |
Carton with curved end and dispensing features
|
CA2808919C
(en)
|
2005-12-22 |
2016-04-19 |
Glaxosmithkline Biologicals S.A. |
Streptococcus pneumoniae capsular saccharide vaccine
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
WO2007082096A2
(en)
|
2006-01-12 |
2007-07-19 |
Graphic Packaging International, Inc. |
Carton with dispenser
|
EP2476434A1
(en)
|
2006-03-30 |
2012-07-18 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
MX2008012698A
(en)
|
2006-04-04 |
2008-10-10 |
Graphic Packaging Int Inc |
Carton with dispenser.
|
EP2032464A1
(en)
*
|
2006-06-23 |
2009-03-11 |
Graphic Packaging International, Inc. |
Carton with dispenser
|
PL2422810T3
(en)
|
2006-07-17 |
2015-03-31 |
Glaxosmithkline Biologicals Sa |
Influenza vaccine
|
WO2008012538A2
(en)
|
2006-07-25 |
2008-01-31 |
The Secretary Of State For Defence |
Live vaccine strains of francisella
|
EP2086582B1
(en)
|
2006-10-12 |
2012-11-14 |
GlaxoSmithKline Biologicals s.a. |
Vaccine comprising an oil in water emulsion adjuvant
|
DK2137210T3
(en)
|
2007-03-02 |
2017-01-30 |
Glaxosmithkline Biologicals Sa |
Hitherto unknown method and compositions
|
TW200908994A
(en)
|
2007-04-20 |
2009-03-01 |
Glaxosmithkline Biolog Sa |
Vaccine
|
FR2917382B1
(en)
*
|
2007-06-15 |
2011-05-20 |
Saica France |
FLAT-TYPE PACKAGING FOR FLAT TRANSPORTATION AND PRESENTATION ON SALE OF CONTENT AFTER RECOVERY
|
EP2687228B1
(en)
|
2007-06-26 |
2017-07-19 |
GlaxoSmithKline Biologicals S.A. |
Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
|
ES2626634T3
(en)
|
2007-12-19 |
2017-07-25 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Soluble forms of Hendra and Nipah virus F glycoprotein and uses thereof
|
AU2008340949A1
(en)
|
2007-12-24 |
2009-07-02 |
Glaxosmithkline Biologicals S.A. |
Recombinant RSV antigens
|
KR20110009157A
(en)
|
2008-04-16 |
2011-01-27 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
Vaccine
|
WO2010079081A1
(en)
|
2009-01-07 |
2010-07-15 |
Glaxosmithkline Biologicals S.A. |
Methods for recovering a virus or a viral antigen produced by cell culture
|
GB0901423D0
(en)
|
2009-01-29 |
2009-03-11 |
Secr Defence |
Treatment
|
GB0901411D0
(en)
|
2009-01-29 |
2009-03-11 |
Secr Defence |
Treatment
|
JP5843615B2
(en)
|
2009-02-06 |
2016-01-13 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
Purification of viruses or viral antigens by density gradient ultracentrifugation
|
AR075437A1
(en)
|
2009-02-17 |
2011-03-30 |
Glaxosmithkline Biolog Sa |
IMMUNOGENIC COMPOSITION THAT INCLUDES AT LEAST ONE ANTIGEN OF THE VIRUS OF THE INACTIVATED DENGUE AND AN ADJUVANT WITHOUT ALUMINUM, METHOD FOR PRODUCING THIS VACCINE AND ITS USE TO PREPARE A MEDICINAL PRODUCT
|
GB0906234D0
(en)
|
2009-04-14 |
2009-05-20 |
Secr Defence |
Vaccine
|
US9492531B2
(en)
|
2009-06-24 |
2016-11-15 |
Glaxosmithkline Biologicals Sa |
Recombinant RSV vaccines
|
MX2012000036A
(en)
|
2009-06-24 |
2012-02-28 |
Glaxosmithkline Biolog Sa |
Vaccine.
|
DK3178490T3
(en)
|
2009-07-15 |
2022-06-20 |
Glaxosmithkline Biologicals Sa |
RSV F protein compositions and methods for their preparation
|
GB0913680D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
BE1018880A3
(en)
*
|
2009-09-09 |
2011-10-04 |
Ags Bvba |
FOLDING BOX FOR PASTRY OR OTHER BANQUET PRODUCTS.
|
CA2774555A1
(en)
|
2009-09-25 |
2011-03-31 |
Glaxosmithkline Biologicals S.A. |
Immunodiffusion assay for influenza virus
|
GB0919117D0
(en)
|
2009-10-30 |
2009-12-16 |
Glaxosmithkline Biolog Sa |
Process
|
CN102858961A
(en)
|
2010-05-03 |
2013-01-02 |
葛兰素史密丝克莱恩生物有限公司 |
Novel method
|
JP5762529B2
(en)
|
2010-05-19 |
2015-08-12 |
グラフィック パッケージング インターナショナル インコーポレイテッド |
Container package
|
GB201009273D0
(en)
|
2010-06-03 |
2010-07-21 |
Glaxosmithkline Biolog Sa |
Novel vaccine
|
EP2598411B1
(en)
|
2010-07-30 |
2016-12-21 |
Graphic Packaging International, Inc. |
Carrier for bottles, blank and method for forming it
|
US8356743B2
(en)
|
2010-09-17 |
2013-01-22 |
Graphic Packaging International, Inc. |
Carton with insert
|
US20130216613A1
(en)
|
2010-10-15 |
2013-08-22 |
Guy Jean Marie Fernand Pierre Baudoux |
Cytomegalovirus gb antigen
|
CN104724389B
(en)
|
2010-12-03 |
2017-04-19 |
印刷包装国际公司 |
Package For Containers
|
US8978889B2
(en)
|
2011-05-06 |
2015-03-17 |
Graphic Packing International, Inc. |
Carton with article protection feature
|
US8701878B2
(en)
|
2011-05-13 |
2014-04-22 |
Graphic Packaging International, Inc. |
Package for beverage containers
|
US20140072622A1
(en)
|
2011-05-17 |
2014-03-13 |
Glaxosmithkline Biologicals S.A. |
Vaccine against streptococcus pneumoniae
|
US8955674B2
(en)
|
2011-08-05 |
2015-02-17 |
Graphic Packaging International, Inc. |
Package for containers
|
JP2015514696A
(en)
|
2012-03-18 |
2015-05-21 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
Vaccination method against human papillomavirus
|
WO2013163499A1
(en)
|
2012-04-27 |
2013-10-31 |
Graphic Packaging International, Inc. |
Carton with insert
|
EP2874905B1
(en)
|
2012-07-17 |
2017-02-22 |
Graphic Packaging International, Inc. |
Carton with insert
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
CA2879939A1
(en)
|
2012-08-06 |
2014-02-13 |
Glaxosmithkline Biologicals S.A. |
Novel method
|
JP6250050B2
(en)
|
2012-08-10 |
2017-12-20 |
グラフィック パッケージング インターナショナル インコーポレイテッドGraphic Packaging International,Inc. |
Carton with dispenser
|
BE1022174B1
(en)
|
2013-03-15 |
2016-02-24 |
Glaxosmithkline Biologicals S.A. |
VACCINE
|
ES2660757T3
(en)
|
2013-05-13 |
2018-03-26 |
Graphic Packaging International, Inc. |
Cardboard box with insertion element
|
AU2014265714B2
(en)
|
2013-05-13 |
2018-05-10 |
Graphic Packaging International, Llc |
Carton with article protection features
|
EP3003896B1
(en)
|
2013-05-24 |
2018-12-05 |
Graphic Packaging International, LLC |
Carton for articles
|
US10384846B2
(en)
|
2013-05-24 |
2019-08-20 |
Graphic Packaging International, Llc |
Arrangement of containers in a carton
|
KR20160040290A
(en)
|
2013-08-05 |
2016-04-12 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
Combination immunogenic compositions
|
ES2778928T3
(en)
|
2013-08-30 |
2020-08-12 |
Glaxosmithkline Biologicals Sa |
Large-scale production of viruses in cell cultures
|
CN104436157A
(en)
|
2013-09-23 |
2015-03-25 |
恩金生物有限公司 |
Influenza vaccine and therapy
|
MX2016004854A
(en)
|
2013-10-25 |
2016-07-06 |
Graphic Packaging Int Inc |
Carton with retention features.
|
US9718246B2
(en)
|
2013-12-10 |
2017-08-01 |
Graphic Packaging International, Inc. |
Carton with article protection features
|
WO2015130584A2
(en)
|
2014-02-25 |
2015-09-03 |
Merck Sharp & Dohme Corp. |
Lipid nanoparticle vaccine adjuvants and antigen delivery systems
|
CA2936590A1
(en)
|
2014-02-28 |
2015-09-03 |
Graphic Packaging International, Inc. |
Carton with article protection features
|
US10322845B2
(en)
|
2014-03-11 |
2019-06-18 |
Graphic Packaging International, Llc |
Carton with insert
|
WO2015138537A1
(en)
|
2014-03-11 |
2015-09-17 |
Graphic Packaging International, Inc. |
Carton with insert
|
WO2015165480A1
(en)
|
2014-04-30 |
2015-11-05 |
Institute For Research In Biomedicine |
Human cytomegalovirus vaccine compositions and method of producing the same
|
JP6664338B2
(en)
|
2014-06-13 |
2020-03-13 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
Immunogenic combination
|
US10124947B2
(en)
|
2014-06-23 |
2018-11-13 |
Graphic Packaging International, Llc |
Carton with dispensing features
|
CN107148388B
(en)
|
2014-10-30 |
2019-08-16 |
印刷包装国际有限责任公司 |
Carton with handle
|
WO2016179474A1
(en)
|
2015-05-07 |
2016-11-10 |
Graphic Packaging International, Inc. |
Carton with handle
|
WO2016207408A1
(en)
|
2015-06-26 |
2016-12-29 |
Institute For Research In Biomedicine |
Novel vaccines in prevention and treatment of malaria
|
US10202228B2
(en)
|
2015-10-09 |
2019-02-12 |
Graphic Packaging International, Llc |
Carton with asymmetrical corners
|
GB201614799D0
(en)
|
2016-09-01 |
2016-10-19 |
Glaxosmithkline Biologicals Sa |
Compositions
|
US20200093909A1
(en)
|
2017-04-19 |
2020-03-26 |
Institute For Research In Biomedicine |
Plasmodium sporozoite npdp peptides as vaccine and target novel malaria vaccines and antibodies binding to
|
EP3581201A1
(en)
|
2018-06-15 |
2019-12-18 |
GlaxoSmithKline Biologicals S.A. |
Escherichia coli o157:h7 proteins and uses thereof
|
USD881690S1
(en)
|
2018-12-31 |
2020-04-21 |
Graphic Packaging International, Llc |
Carton
|
USD885887S1
(en)
|
2019-01-03 |
2020-06-02 |
Graphic Packaging International, Llc |
Carton
|
USD898565S1
(en)
|
2019-04-23 |
2020-10-13 |
Graphic Packaging International, Llc |
Carton
|
EP4004018A1
(en)
|
2019-07-24 |
2022-06-01 |
GlaxoSmithKline Biologicals SA |
Modified human cytomegalovirus proteins
|
MX2023006320A
(en)
|
2020-12-02 |
2023-06-14 |
Glaxosmithkline Biologicals Sa |
Donor strand complemented fimh.
|
WO2022161598A1
(en)
|
2021-01-26 |
2022-08-04 |
Eth Zurich |
Antibodies broadly targeting coronaviruses and uses thereof
|
WO2022162012A2
(en)
|
2021-01-26 |
2022-08-04 |
Eth Zurich |
Antibodies broadly targeting coronaviruses and uses thereof
|
WO2023144665A1
(en)
|
2022-01-28 |
2023-08-03 |
Glaxosmithkline Biologicals Sa |
Modified human cytomegalovirus proteins
|